Mefloquine and ECG abnormalities
Result of checking the interaction of drug Mefloquine and disease ECG abnormalities for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Mefloquine is a myocardial depressant. Animal studies with parenteral mefloquine indicate that the drug possesses 20% of the antifibrillatory action of quinidine and produces 50% of the increase in the PR interval reported with quinine. The effect of mefloquine on the compromised cardiovascular system has not been evaluated. However, transient and asymptomatic ECG alterations have been reported during the use of mefloquine, including sinus bradycardia, sinus arrhythmia, first-degree AV block, prolongation of the QTc interval, and abnormal T waves. In postmarketing use, hypotension, hypertension, flushing, syncope, chest pain, tachycardia, palpitation, bradycardia, irregular pulse, extrasystoles, AV block, and other transient cardiac conduction alterations have been reported rarely. Therapy with mefloquine should be administered cautiously in patients with cardiac disease and only if potential benefits justify the risks.
Mefloquine - Nieprawidłowości w EKG 
Mefloquine - Anormalidades de ECG 
Mefloquine - Keabnormalan ECG 
Mefloquine - Kelainan EKG 
Mefloquine - Anomalie dell'ECG 
Mefloquine - Anomalies ECG 
Mefloquine - EKG-Anomalien 
Mefloquine - Anomalías del ECG 
Mefloquine - ЭКГ отклонения 
Mefloquine - EKG anormallikleri 
Mefloquine - تشوهات تخطيط القلب 
Mefloquine - 心电图异常